Montelukast (Singulair) Warning – FDA

The U.S. Food and Drug Administration (FDA) announced that it is requiring a boxed warning for montelukast (Singulair) due to the risk of neuropsychiatric events, such as agitation, depression, sleeping problems and suicidal thought and actions. The actual incidence of neuropsychiatric events associated with montelukast is unknown. As with any drug, the risks vs the benefits should be weighed...
read more

Pretzel Recall

Baptista’s Bakery, Inc. announced a voluntary recall of a limited number of 30 oz. Snack Factory® Original Pretzel Crisps® packages because they may contain undeclared milk ingredients. People who have an allergy or severe sensitivity to milk run the risk of a serious or life threatening allergic reaction if they consume the affected product. See full recall information from the FDA...
read more